Table 1 Clinical characteristics of the subjects.
Variables | Total (n = 1351) |
|---|---|
Age, year | 63 ± 14 |
Men, n (%) | 812 (60.1) |
Body mass index, kg/m2 | 24.2 ± 4.2 |
Systolic blood pressure, mmHg | 133 ± 19 |
Diastolic blood pressure, mmHg | 79 ± 12 |
Heart rate, bpm | 71 ± 12 |
Total cholesterol, mmol/L | 4.99 ± 0.98 |
Triglycerides, mmol/L | 1.58 ± 1.05 |
HDL cholesterol, mmol/L | 1.53 ± 0.44 |
LDL cholesterol, mmol/L | 2.92 ± 0.88 |
Glucose, mmol/L | 6.61 ± 2.39 |
Hemoglobin A1c, % | 5.8 ± 0.9 |
BUN, mmol/L | 5.71 ± 1.89 |
Creatinine, umol/L | 73.4 ± 25.6 |
eGFR, mL/min/1.73 m2 | 71 ± 20 |
hs-CRP, mg/dL | 0.16 ± 0.34 |
Medical history, n (%) | |
Hypertension | 1051 (77.8) |
Dyslipidemia | 853 (63.1) |
Diabetes mellitus | 444 (32.9) |
Previous coronary heart disease | 210 (15.5) |
Previous stroke | 94 (7.0) |
Current smoker, n (%) | 229 (17.0) |
Medication, n (%) | |
Antiplatelets | 314 (23.2) |
Calcium channel blockers | 641 (47.4) |
ACEIs or ARBs | 511 (37.8) |
β-blockers | 282 (20.9) |
Diuretics | 161 (11.9) |
Statins | 500 (37.0) |
Medically treated diabetes mellitus | |
Any | 307 (22.7) |
Insulin dependent | 35 (2.6) |
Baseline BAD, mm | 4.1 ± 0.7 |
FMD, % | 3.7 ± 2.8 |
NID, % | 11.8 ± 5.9 |
